← Evidence map

ArticleNPJ breast cancer2021

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.

Douglas Yee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34611148